Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer-Reference-Cited by-同舟云学术

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer

Published:2023-08-08 Issue:16 Volume:66 Page:11250-11270
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ordonez-Rubiano Sandra C.¹^ORCID,Maschinot Chad A.¹,Wang Sijie¹,Sood Surbhi¹,Baracaldo-Lancheros Luisa F.¹,Strohmier Brayden P.¹,McQuade Alexander J.¹,Smith Brian C.²^ORCID,Dykhuizen Emily C.¹³^ORCID

Affiliation:

1. Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University. Robert Heine Pharmacy Building 575 Stadium Mall Drive, West Lafayette, Indiana 47907, United States

2. Department of Biochemistry, Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States

3. Purdue Center for Cancer Research, College of Pharmacy, Purdue University, 201 S University St., West Lafayette, Indiana 47907, United States

Funder

National Cancer Institute

National Institute of General Medical Sciences

Purdue University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00671